Development and validation of a rapid and sensitive high-performance liquid chromatography-mass spectroscopy assay for determination of 17-(allylamino)-17-demethoxygeldanamycin and 17-(amino)-17-demethoxygeldanamycin in human plasma
about
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia.Development and Validation of a Stability Indicating LC Method for the Assay and Related Substances Determination of a Proteasome Inhibitor Bortezomib
P2860
Development and validation of a rapid and sensitive high-performance liquid chromatography-mass spectroscopy assay for determination of 17-(allylamino)-17-demethoxygeldanamycin and 17-(amino)-17-demethoxygeldanamycin in human plasma
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Development and validation of ...... xygeldanamycin in human plasma
@ast
Development and validation of ...... xygeldanamycin in human plasma
@en
type
label
Development and validation of ...... xygeldanamycin in human plasma
@ast
Development and validation of ...... xygeldanamycin in human plasma
@en
prefLabel
Development and validation of ...... xygeldanamycin in human plasma
@ast
Development and validation of ...... xygeldanamycin in human plasma
@en
P2093
P2860
P1476
Development and validation of ...... xygeldanamycin in human plasma
@en
P2093
Jeffrey S Johnston
Katherine L Farley
Kristie A Blum
Michael R Grever
Mitch A Phelps
William Blum
P2860
P356
10.1016/J.JCHROMB.2008.06.029
P577
2008-06-26T00:00:00Z